Preoperative Chemoradiotherapy with Capecitabine and Oxaliplatin in Locally Advanced Rectal Cancer. A Phase I–II Multicenter Study of the Dutch Colorectal Cancer Group

Author： Hospers Geke   Punt Cornelis   Tesselaar Margot   Cats Annemieke   Havenga Klaas   Leer Jan   Marijnen Corrie   Jansen Edwin   Krieken Han   Wiggers Theo   Velde Cornelis   Mulder Nanno  

Publisher： Springer Publishing Company

ISSN： 1068-9265

Source： Annals of Surgical Oncology, Vol.14, Iss.10, 2007-10, pp. : 2773-2779

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Multicenter phase II clinical trial of preoperative capecitabine with concurrent radiotherapy in patients with locally advanced rectal cancer

By las Heras Manuel  

Clinical and Translational Oncology, Vol. 15, Iss. 4, 2013-04 ,pp. : 294-299

Springer Publishing Company

Access to resources Recommend Favorite

A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer

By Chao Yee   Hsieh Jan-Sing   Yeh Hsien-Tang   Su Yu-Chieh   Wu Cheng-Chung   Chen Jen-Shi   Tai Cheng-Jeng   Bai Li-Yuan   Yeh Kun-Huei   Su Wu-Chou   Li Chung-Pin  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 4, 2014-04 ,pp. : 799-806

Springer Publishing Company

Access to resources Recommend Favorite

Multicenter phase II study of oral capecitabine plus irinotecan as first-line chemotherapy in advanced colorectal cancer: A Korean Cancer Study Group Trial

By Kim Tae Won   Kang Won Ki   Chang Heung Moon   Park Joon Oh   Ryoo Baek Yeol   Ahn Jin Seok   Zang Dae Young   Lee Kyung Hee   Kang Yoon Koo   Kim Sung Rok   Kim Hoon-Kyo  

Acta Oncologica, Vol. 44, Iss. 3, 2005-05 ,pp. : 230-235

Informa Healthcare

Access to resources Recommend Favorite

Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients: phase II study

By Santini Daniele   Vincenzi Bruno   Schiavon Gaia   Di Seri Marisa   Virzí Vladimir   Spalletta Bruno   Caricato Marco   Coppola Roberto   Tonini Giuseppe  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 5, 2007-04 ,pp. : 613-620

Springer Publishing Company

Access to resources Recommend Favorite

Neoadjuvant chemoradiotherapy with or without panitumumab in patients with wild-type KRAS , locally advanced rectal cancer (LARC): a randomized, multicenter, phase II trial SAKK 41/07

By Helbling D.   Bodoky G.   Gautschi O.   Sun H.   Bosman F.   Gloor B.   Burkhard R.   Winterhalder R.   Madlung A.   Rauch D.   Saletti P.   Widmer L.   Borner M.   Baertschi D.   Yan P.   Benhattar J.   Leibundgut E. O.   Bougel S.   Koeberle D.  

Annals of Oncology, Vol. 24, Iss. 3, 2013-03 ,pp. : 718-725

Oxford University Press

Access to resources Recommend Favorite